الرئيسية › سرطان القولون والمستقيم › كارولاينا الشمالية › Durham
التجارب السريرية لـ سرطان القولون والمستقيم في Durham، NC
28 دراسات لـ سرطان القولون والمستقيم تبحث عن مشاركين في مواقع داخل وحول Durham (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
The Vanguard Study: Testing a New Way to Screen for Cancer
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · على بُعد 10 ميل
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
جارٍ التسجيلالمرحلة 3
- Duke University Medical Center /ID# 279322, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
جارٍ التسجيلالمرحلة 1/2
- Duke University, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Durham VA Medical Center, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
جارٍ التسجيلالمرحلة 1
- Exelixis Clinical Site #12, Durham
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
جارٍ التسجيلالمرحلة 3
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
جارٍ التسجيلالمرحلة 1/2
- Duke Cancer Center, Durham
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
جارٍ التسجيلالمرحلة 2
- University of North Carolina Medical Center /ID# 267786, Chapel Hill · على بُعد 10 ميل
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
جارٍ التسجيلالمرحلة 3
- University of North Carolina at Chapel Hill, Chapel Hill · على بُعد 10 ميل
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
جارٍ التسجيلالمرحلة 3
- Duke University Medical Center, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
جارٍ التسجيلالمرحلة 1
- Duke University Medical Center, Durham
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Duke University Medical Center, Durham
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
جارٍ التسجيلالمرحلة 1/2
- Duke University School of Medicine, Durham
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
جارٍ التسجيلالمرحلة 3
- The University of North Carolina At Chapel Hill, Chapel Hill · على بُعد 10 ميل
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
جارٍ التسجيلالمرحلة 3
- Duke Cancer Center, Durham
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
جارٍ التسجيلالمرحلة 1
- Duke University Medical Center, Durham
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
جارٍ التسجيلالمرحلة 2
- Duke University Medical Center - Duke Cancer Center, Durham
FOG-001 in Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Duke University, Durham
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
جارٍ التسجيلالمرحلة 1/2
- GSK Investigational Site, Durham
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1
- Duke Cancer Center, Durham
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
جارٍ التسجيلالمرحلة 3
- Duke University Hospital, Durham
- Duke University Medical Center, Duke Cancer Center, Durham
- Duke University Medical Center, Durham
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
جارٍ التسجيلالمرحلة 2
- Duke University Medical Center, Durham
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
جارٍ التسجيل
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · على بُعد 10 ميل
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
جارٍ التسجيلالمرحلة 2
- Duke University Medical Center /ID# 279457, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
جارٍ التسجيلالمرحلة 1
- Research Site, Durham
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
جارٍ التسجيلالمرحلة 1/2
- Duke University Medical Center, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
جارٍ التسجيلالمرحلة 1
- Duke Cancer Center, Durham
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
جارٍ التسجيل
- Duke Cancer Institute, Durham
تجارب سرطان القولون والمستقيم في مدن أخرى
- Houston, TX102 دراسات
- New York City, NY78 دراسات
- Nashville, TN69 دراسات
- Boston, MA63 دراسات
- Los Angeles, CA59 دراسات
- Arlington, VA52 دراسات
- St. Louis, MO50 دراسات
- San Antonio, TX46 دراسات
- Philadelphia, PA44 دراسات
- Grand Rapids, MI40 دراسات
- Baldwin Park, CA37 دراسات
- Chicago, IL34 دراسات
دراسات أخرى في Durham
- سرطان الثدي64 دراسات
- السرطان (جميع الأنواع)58 دراسات
- سرطان الرئة غير صغير الخلايا39 دراسات
- الورم النقوي المتعدد37 دراسات
- ابيضاض الدم النقوي الحاد33 دراسات
- السرطان النقيلي33 دراسات
- سرطان البروستاتا32 دراسات
- سرطان الرئة32 دراسات
- سرطان المبيض27 دراسات
- ابيضاض الدم اللمفاوي المزمن27 دراسات
- قصور القلب26 دراسات
- سرطان البنكرياس24 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.